Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21

Cancer Cell

Volumn 18, Issue 3, 2010, Pages 282-293

  Hatley, Mark E ^a,b   Patrick, David M ^b   Garcia, Matthew R ^a   Richardson, James A ^a,b   Bassel Duby, Rhonda ^b   van Rooij, Eva ^b,c   Olson, Eric N ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c MiRagen Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

K RAS PROTEIN; MICRORNA 21; MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN; MICRORNA; MIRN21 MICRORNA, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; DNA DAMAGE; ENZYME ACTIVATION; ENZYME INHIBITION; GENE DELETION; GENE FREQUENCY; GENE OVEREXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG CARCINOGENESIS; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ANIMAL; CELL TRANSFORMATION; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; NON SMALL CELL LUNG CANCER; NUDE MOUSE; ONCOGENE RAS; PATHOLOGY; TRANSGENIC MOUSE; TUMOR CELL LINE;

MUS MUSCULUS;

ANIMALS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICRORNAS; SIGNAL TRANSDUCTION;

EID: 77956501846     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2010.08.013     Document Type: Article

References (69)

1. Afonja O., Juste D., Das S., Matsuhashi S., Samuels H.H. Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 2004, 23:8135-8145.
2. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
3. Badillo-Almaraz I., Badillo-Salas C., Villalobos R., Avalos-Diaz E., Herrera-Esparza R. Defective expression of FasL and Bax in human lung cancer. Clin. Exp. Med. 2003, 3:106-112.
4. Baek D., Villen J., Shin C., Camargo F.D., Gygi S.P., Bartel D.P. The impact of microRNAs on protein output. Nature 2008, 455:64-71.
5. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
6. Bitomsky N., Wethkamp N., Marikkannu R., Klempnauer K.H. siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression. Oncogene 2008, 27:4820-4829.
7. Blower P.E., Chung J.H., Verducci J.S., Lin S., Park J.K., Dai Z., Liu C.G., Schmittgen T.D., Reinhold W.C., Croce C.M., et al. MicroRNAs modulate the chemosensitivity of tumor cells. Mol. Cancer Ther. 2008, 7:1-9.
8. Buganim Y., Solomon H., Rais Y., Kistner D., Nachmany I., Brait M., Madar S., Goldstein I., Kalo E., Adam N., et al. p53 Regulates the Ras circuit to inhibit the expression of a cancer-related gene signature by various molecular pathways. Cancer Res. 2010, 70:2274-2284.
9. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6:857-866.
10. Casci T., Vinos J., Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell 1999, 96:655-665.
11. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
12. Chen Y., Knosel T., Kristiansen G., Pietas A., Garber M.E., Matsuhashi S., Ozaki I., Petersen I. Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J. Pathol. 2003, 200:640-646.
13. Cho W.C. OncomiRs: The discovery and progress of microRNAs in cancers. Mol. Cancer 2007, 6:60.
14. Ciafre S.A., Galardi S., Mangiola A., Ferracin M., Liu C.G., Sabatino G., Negrini M., Maira G., Croce C.M., Farace M.G. Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem. Biophys. Res. Commun. 2005, 334:1351-1358.
15. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
16. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283:1026-1033.
17. Fukuda T., Mishina Y., Walker M.P., DiAugustine R.P. Conditional transgenic system for mouse aurora a kinase: Degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein. Mol. Cell. Biol. 2005, 25:5270-5281.
18. Goke R., Barth P., Schmidt A., Samans B., Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am. J. Physiol. Cell Physiol. 2004, 287:C1541-C1546.
19. Grimson A., Farh K.K., Johnston W.K., Garrett-Engele P., Lim L.P., Bartel D.P. MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell 2007, 27:91-105.
20. Hanafusa H., Torii S., Yasunaga T., Nishida E. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway. Nat. Cell Biol. 2002, 4:850-858.
21. Huang T.H., Wu F., Loeb G.B., Hsu R., Heidersbach A., Brincat A., Horiuchi D., Lebbink R.J., Mo Y.Y., Goga A., McManus M.T. Up-regulation of miR-21 by HER2/neu signaling promotes cell invasion. J. Biol. Chem. 2009, 284:18515-18524.
22. Hutvagner G., Simard M.J., Mello C.C., Zamore P.D. Sequence-specific inhibition of small RNA function. PLoS Biol. 2004, 2:E98.
23. Hwang S.K., Jin H., Kwon J.T., Chang S.H., Kim T.H., Cho C.S., Lee K.H., Young M.R., Colburn N.H., Beck G.R., et al. Aerosol-delivered programmed cell death 4 enhanced apoptosis, controlled cell cycle and suppressed AP-1 activity in the lungs of AP-1 luciferase reporter mice. Gene Ther. 2007, 14:1353-1361.
24. Iorio M.V., Visone R., Di Leva G., Donati V., Petrocca F., Casalini P., Taccioli C., Volinia S., Liu C.G., Alder H., et al. MicroRNA signatures in human ovarian cancer. Cancer Res. 2007, 67:8699-8707.
25. Jansen A.P., Camalier C.E., Colburn N.H. Epidermal expression of the translation inhibitor programmed cell death 4 suppresses tumorigenesis. Cancer Res. 2005, 65:6034-6041.
26. Johnson L., Mercer K., Greenbaum D., Bronson R.T., Crowley D., Tuveson D.A., Jacks T. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice. Nature 2001, 410:1111-1116.
27. Kim D.M., Chung K.S., Choi S.J., Jung Y.J., Park S.K., Han G.H., Ha J.S., Song K.B., Choi N.S., Kim H.M., et al. RhoB induces apoptosis via direct interaction with TNFAIP1 in HeLa cells. Int. J. Cancer 2009, 125:2520-2527.
28. Kota J., Chivukula R.R., O'Donnell K.A., Wentzel E.A., Montgomery C.L., Hwang H.W., Chang T.C., Vivekanandan P., Torbenson M., Clark K.R., et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009, 137:1005-1017.
29. Krek A., Grun D., Poy M.N., Wolf R., Rosenberg L., Epstein E.J., MacMenamin P., da Piedade I., Gunsalus K.C., Stoffel M., Rajewsky N. Combinatorial microRNA target predictions. Nat. Genet. 2005, 37:495-500.
30. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005, 438:685-689.
31. Lawrie C.H., Soneji S., Marafioti T., Cooper C.D., Palazzo S., Paterson J.C., Cattan H., Enver T., Mager R., Boultwood J., et al. MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma. Int. J. Cancer 2007, 121:1156-1161.
32. Lewis B.P., Burge C.B., Bartel D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20.
33. Liu M., Wu H., Liu T., Li Y., Wang F., Wan H., Li X., Tang H. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 2009, 19:828-837.
34. Lo T.L., Fong C.W., Yusoff P., McKie A.B., Chua M.S., Leung H.Y., Guy G.R. Sprouty and cancer: The first terms report. Cancer Lett. 2006, 242:141-150.
35. Lu Z., Liu M., Stribinskis V., Klinge C.M., Ramos K.S., Colburn N.H., Li Y. MicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene. Oncogene 2008, 27:4373-4379.
36. Lui W.O., Pourmand N., Patterson B.K., Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007, 67:6031-6043.
37. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., Teruya-Feldstein J., Reinhardt F., Onder T.T., Valastyan S., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat. Cell Biol. 2010, 12:247-256.
38. Markou A., Tsaroucha E.G., Kaklamanis L., Fotinou M., Georgoulias V., Lianidou E.S. Prognostic value of mature MicroRNA-21 and MicroRNA-205 overexpression in non-small cell lung cancer by quantitative real-time RT-PCR. Clin. Chem. 2008, 54:1696-1704.
39. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658.
40. Minowada G., Miller Y.E. Sprouty 2 gene in mouse lung tumorigenesis. Chest 2004, 125(5 Suppl):111S.
41. Minowada G., Miller Y.E. Overexpression of Sprouty 2 in mouse lung epithelium inhibits urethane-induced tumorigenesis. Am. J. Respir. Cell Mol. Biol. 2009, 40:31-37.
42. Nikitin A.Y., Alcaraz A., Anver M.R., Bronson R.T., Cardiff R.D., Dixon D., Fraire A.E., Gabrielson E.W., Gunning W.T., Haines D.C., et al. Classification of proliferative pulmonary lesions of the mouse: Recommendations of the mouse models of human cancers consortium. Cancer Res. 2004, 64:2307-2316.
43. Parkin D.M., Bray F.I., Devesa S.S. Cancer burden in the year 2000: The global picture. Eur. J. Cancer 2001, 37(Suppl 8):S4-S66.
44. Ramalingam S., Pawlish K., Gadgeel S., Demers R., Kalemkerian G.P. Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database. J. Clin. Oncol. 1998, 16:651-657.
45. Sato N., Fukui T., Taniguchi T., Yokoyama T., Kondo M., Nagasaka T., Goto Y., Gao W., Ueda Y., Yokoi K., et al. RhoB is frequently downregulated in non-small-cell lung cancer and resides in the 2p24 homozygous deletion region of a lung cancer cell line. Int. J. Cancer 2007, 120:543-551.
46. Sayed D., Rane S., Lypowy J., He M., Chen I.Y., Vashistha H., Yan L., Malhotra A., Vatner D., Abdellatif M. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol. Biol. Cell 2008, 19:3272-3282.
47. Seike M., Goto A., Okano T., Bowman E.D., Schetter A.J., Horikawa I., Mathe E.A., Jen J., Yang P., Sugimura H., et al. MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc. Natl. Acad. Sci. USA 2009, 106:12085-12090.
48. Selbach M., Schwanhausser B., Thierfelder N., Fang Z., Khanin R., Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 2008, 455:58-63.
49. Selcuklu S.D., Donoghue M.T., Spillane C. miR-21 as a key regulator of oncogenic processes. Biochem. Soc. Trans. 2009, 37:918-925.
50. Shaw A.T., Meissner A., Dowdle J.A., Crowley D., Magendantz M., Ouyang C., Parisi T., Rajagopal J., Blank L.J., Bronson R.T., et al. Sprouty-2 regulates oncogenic K-ras in lung development and tumorigenesis. Genes Dev. 2007, 21:694-707.
51. Si M.L., Zhu S., Wu H., Lu Z., Wu F., Mo Y.Y. miR-21-mediated tumor growth. Oncogene 2007, 26:2799-2803.
52. Soon Y.Y., Stockler M.R., Askie L.M., Boyer M.J. Duration of chemotherapy for advanced non-small-cell lung cancer: A systematic review and meta-analysis of randomized trials. J. Clin. Oncol. 2009, 27:3277-3283.
53. Subramanian S., Lui W.O., Lee C.H., Espinosa I., Nielsen T.O., Heinrich M.C., Corless C.L., Fire A.Z., van de Rijn M. MicroRNA expression signature of human sarcomas. Oncogene 2008, 27:2015-2026.
54. Sutterluty H., Mayer C.E., Setinek U., Attems J., Ovtcharov S., Mikula M., Mikulits W., Micksche M., Berger W. Down-regulation of Sprouty2 in non-small cell lung cancer contributes to tumor malignancy via extracellular signal-regulated kinase pathway-dependent and -independent mechanisms. Mol. Cancer Res. 2007, 5:509-520.
55. Talotta F., Cimmino A., Matarazzo M.R., Casalino L., De Vita G., D'Esposito M., Di Lauro R., Verde P. An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation. Oncogene 2009, 28:73-84.
56. Tran N., McLean T., Zhang X., Zhao C.J., Thomson J.M., O'Brien C., Rose B. MicroRNA expression profiles in head and neck cancer cell lines. Biochem. Biophys. Res. Commun. 2007, 358:12-17.
57. van Rooij E., Sutherland L.B., Liu N., Williams A.H., McAnally J., Gerard R.D., Richardson J.A., Olson E.N. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc. Natl. Acad. Sci. USA 2006, 103:18255-18260.
58. van Rooij E., Sutherland L.B., Thatcher J.E., DiMaio J.M., Naseem R.H., Marshall W.S., Hill J.A., Olson E.N. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc. Natl. Acad. Sci. USA 2008, 105:13027-13032.
59. Ventura A., Jacks T. MicroRNAs and cancer: Short RNAs go a long way. Cell 2009, 136:586-591.
60. Volinia S., Calin G.A., Liu C.G., Ambs S., Cimmino A., Petrocca F., Visone R., Iorio M., Roldo C., Ferracin M., et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA 2006, 103:2257-2261.
61. Voorhoeve P.M., Agami R. Classifying microRNAs in cancer: The good, the bad and the ugly. Biochim. Biophys. Acta 2007, 1775:274-282.
62. Wang P., Zou F., Zhang X., Li H., Dulak A., Tomko R.J., Lazo J.S., Wang Z., Zhang L., Yu J. microRNA-21 negatively regulates Cdc25A and cell cycle progression in colon cancer cells. Cancer Res. 2009, 69:8157-8165.
63. Xie Y., Todd N.W., Liu Z., Zhan M., Fang H., Peng H., Alattar M., Deepak J., Stass S.A., Jiang F. Altered miRNA expression in sputum for diagnosis of non-small cell lung cancer. Lung Cancer 2010, 67:170-176.
64. Yanaihara N., Caplen N., Bowman E., Seike M., Kumamoto K., Yi M., Stephens R.M., Okamoto A., Yokota J., Tanaka T., et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006, 9:189-198.
65. Yang H.S., Jansen A.P., Komar A.A., Zheng X., Merrick W.C., Costes S., Lockett S.J., Sonenberg N., Colburn N.H. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 2003, 23:26-37.
66. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001, 20:669-676.
67. Zhang H., Ozaki I., Mizuta T., Hamajima H., Yasutake T., Eguchi Y., Ideguchi H., Yamamoto K., Matsuhashi S. Involvement of programmed cell death 4 in transforming growth factor-beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006, 25:6101-6112.
68. Zhang Z., Li Z., Gao C., Chen P., Chen J., Liu W., Xiao S., Lu H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest. 2008, 88:1358-1366.
69. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res. 2008, 18:350-359.